Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31576 - 31600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	DTNA	1837	downregulated	Cisplatin results in decreased expression of DTNA mRNA	18q12.1	A22204
Cisplatin	Approved Investigational	DUSP1	1843	upregulated	Cisplatin results in increased expression of DUSP1 mRNA	5q35.1	A22212
Cisplatin	Approved Investigational	DUSP11	8446	upregulated	Cisplatin results in increased expression of DUSP11 mRNA	2p13.1	A22204
Cisplatin	Approved Investigational	DUSP14	11072	downregulated	Cisplatin results in decreased expression of DUSP14 mRNA	17q12	A21499
Cisplatin	Approved Investigational	DUSP14	11072	upregulated	Cisplatin results in increased expression of DUSP14 mRNA	17q12	A22204 A22212
Cisplatin	Approved Investigational	DUSP22	56940	upregulated	Cisplatin results in increased expression of DUSP22 mRNA	6p25.3	A20427
Cisplatin	Approved Investigational	DUSP5	1847	upregulated	Cisplatin results in increased expression of DUSP5 mRNA	10q25.2	A20427
Cisplatin	Approved Investigational	DYM	54808	downregulated	Cisplatin results in decreased expression of DYM mRNA	18q21.1	A22204
Cisplatin	Approved Investigational	DYRK3	8444	upregulated	Cisplatin results in increased expression of DYRK3 mRNA	1q32.1	A22204
Cisplatin	Approved Investigational	E2F1	1869	downregulated	Cisplatin results in decreased expression of E2F1 mRNA	20q11.22	A21499
Cisplatin	Approved Investigational	E2F1	1869	upregulated	Cisplatin results in increased expression of E2F1 mRNA	20q11.22	A22211
Cisplatin	Approved Investigational	E2F3	1871	downregulated	Cisplatin results in decreased expression of E2F3 mRNA	6p22.3	A22211
Cisplatin	Approved Investigational	EBLN2	55096	downregulated	Cisplatin results in decreased expression of EBLN2 mRNA	3p13	A20427
Cisplatin	Approved Investigational	ECE2	9718	downregulated	Cisplatin results in decreased expression of ECE2 mRNA	3q27.1	A22204
Cisplatin	Approved Investigational	EDA2R	60401	upregulated	Cisplatin results in increased expression of EDA2R mRNA	Xq12	A20427
Cisplatin	Approved Investigational	EDN1	1906	upregulated	Cisplatin results in increased expression of EDN1 mRNA	6p24.1	A22233
Cisplatin	Approved Investigational	EDNRB	1910	upregulated	Cisplatin results in increased expression of EDNRB mRNA	13q22.3	A20660
Cisplatin	Approved Investigational	EEFSEC	60678	downregulated	Cisplatin results in decreased expression of EEFSEC mRNA	3q21.3	A22204
Cisplatin	Approved Investigational	EFNA1	1942	downregulated	Cisplatin results in decreased expression of EFNA1 mRNA	1q22	A20427
Cisplatin	Approved Investigational	EHBP1	23301	downregulated	Cisplatin results in decreased expression of EHBP1 mRNA	2p15	A22204
Cisplatin	Approved Investigational	EID2	163126	downregulated	Cisplatin results in decreased expression of EID2 mRNA	19q13.2	A22204
Cisplatin	Approved Investigational	EIF1	10209	upregulated	Cisplatin results in increased expression of EIF1 mRNA	17q21.2	A22211 A20427
Cisplatin	Approved Investigational	EIF2AK2	5610	downregulated	Cisplatin results in decreased expression of EIF2AK2 mRNA	2p22.2	A22205
Cisplatin	Approved Investigational	EIF2AK4	440275	downregulated	Cisplatin results in decreased expression of EIF2AK4 mRNA	15q15.1	A22205
Cisplatin	Approved Investigational	EIF2B1	1967	upregulated	Cisplatin results in increased expression of EIF2B1 mRNA	12q24.31	A22205

Displaying entries 31576 - 31600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability